Showing results (141-150 of 208) with videos related to
Sort By:
Pageof 21
Oncology Reports|May 19, 2011
Antibacterial activity of adriamycin against bacillus Calmette-GuerinY Mizutani, O Yoshida, I Toida, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1989
Liposomes can function as targets for natural killer cytotoxic factor but not for tumor necrosis factorR C Roozemond, D C Urli, J Jansen, et al.Cancer|March 15, 1997
Doxorubicin sensitizes human bladder carcinoma cells to Fas-mediated cytotoxicityY Mizutani, Y Okada, O Yoshida, et al.Journal of Immunological Methods|August 26, 1983
Enzyme-linked immunosorbent assay for HLA determination on fresh and dried lymphocytesA Bishara, C Brautbar, A Marbach, et al.The Journal of Experimental Medicine|November 1, 1988
The SJL/J T cell response to both spontaneous and transplantable syngeneic reticulum cell sarcoma is mediated predominantly by the V beta 17a+ T cell clonotypeJ D Katz, K Ohnishi, L T Lebow, et al.Neuroimmunomodulation|January 1, 1995
Natural killer cell anergy to cytokine stimulants in a subgroup of patients with heart failure: relationship to norepinephrineD L Vredevoe, D K Moser, X H Gan, et al.Cancer Research|April 15, 1996
Resistance of AIDS-associated Kaposi's sarcoma cells to Fas-mediated apoptosisS Mori, K Murakami-Mori, A Jewett, et al.International Journal of Oncology|September 24, 1999
Selectivity of TRAIL-mediated apoptosis of cancer cells and synergy with drugs: the trail to non-toxic cancer therapeutics (review)B Bonavida, C P Ng, A Jazirehi, et al.Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|November 22, 2005
Can we develop biomarkers that predict response of cancer patients to immunotherapy?B Bonavida, S Huerta-Yepez, L Goodglick, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 5, 1999
Sensitization of AIDS-Kaposi's sarcoma cells to Apo-2 ligand-induced apoptosis by actinomycin DS Mori, K Murakami-Mori, S Nakamura, et al.Pageof 21